163 related articles for article (PubMed ID: 9543595)
1. Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis.
Daimon S; Koni I
Clin Nephrol; 1998 Mar; 49(3):145-52. PubMed ID: 9543595
[TBL] [Abstract][Full Text] [Related]
2. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of morphological and clinical changes in mesangial proliferative glomerulonephritis].
Danilewicz M; Kałuzyński A; Wagrowska-Danilewicz M; Bechcińska B; Zabicka H
Wiad Lek; 1992 Jun; 45(11-12):433-5. PubMed ID: 1279900
[TBL] [Abstract][Full Text] [Related]
4. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
[TBL] [Abstract][Full Text] [Related]
5. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
[TBL] [Abstract][Full Text] [Related]
6. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
Ivanova LV; Shilov EM; Ivanov AA; Kozlovskaia LV; Rudolph P; Proppe D
Ter Arkh; 2003; 75(6):11-7. PubMed ID: 12920952
[TBL] [Abstract][Full Text] [Related]
7. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
9. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy.
Tsuboi N; Kawamura T; Ishii T; Utsunomiya Y; Hosoya T
Nephrol Dial Transplant; 2009 Mar; 24(3):892-9. PubMed ID: 18922859
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
Taguchi T; Bohle A
Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
[TBL] [Abstract][Full Text] [Related]
11. Morphometric comparison of the quantity of the mesangial deposits in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2001; 197(8):545-50. PubMed ID: 11518047
[TBL] [Abstract][Full Text] [Related]
12. [The morphological heterogeneity of mesangioproliferative glomerulonephritis].
Gasanov AB; Varshavskiĭ VA; Serov VV
Arkh Patol; 1990; 52(9):46-51. PubMed ID: 2270980
[TBL] [Abstract][Full Text] [Related]
13. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
14. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T; Oka M; Maesato K; Mano T; Ikee R; Moriya H; Kobayashi S
Hypertens Res; 2008 Mar; 31(3):387-94. PubMed ID: 18497456
[TBL] [Abstract][Full Text] [Related]
15. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
Lee HS; Lim SD
Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
[TBL] [Abstract][Full Text] [Related]
16. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
[TBL] [Abstract][Full Text] [Related]
17. [Histological classification of chronic glomerular diseases].
Noël LH; Gubler MC
Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
19. Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy.
Sato M; Hotta O; Taguma Y
J Pathol; 2002 May; 197(1):14-9. PubMed ID: 12081198
[TBL] [Abstract][Full Text] [Related]
20. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model).
Jefferson JA; Johnson RJ
J Nephrol; 1999; 12(5):297-307. PubMed ID: 10630692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
